Showing 261 - 280 results of 3,105 for search '"amyotrophic lateral sclerosis"', query time: 0.15s Refine Results
  1. 261
  2. 262
  3. 263
  4. 264
  5. 265
  6. 266
  7. 267
  8. 268
  9. 269
  10. 270
  11. 271
  12. 272
  13. 273
  14. 274
  15. 275

    Association of cerebral spinal fluid copper imbalance in amyotrophic lateral sclerosis by Qiao Yi Chen, Peng Wu, Ting Wen, Xing Qin, Ronghua Zhang, Rui Jia, Jiaoting Jin, Fangfang Hu, Xiaoge Xie, Jingxia Dang

    Published 2022-11-01
    “…A plethora of environmental risk factors has been persistently implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS), including metal/metalloids. …”
    Get full text
    Article
  16. 276
  17. 277

    Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis by HaEun Cho, Surabhi Shukla

    Published 2020-12-01
    “…Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, is a progressive and fatal neurodegenerative disease that leads to a loss of muscle control due to nerve cells being affected in the brain and spinal cord. …”
    Get full text
    Article
  18. 278
  19. 279

    Venous blood parameters in determination of respiratory impairment in amyotrophic lateral sclerosis by Xianghua He, Jian Yang, Jiaming Feng, Hongyan Huang, Xiaolin Dong, Quanzhen Zhao, Qiuyan Shen, Caiyou Hu, Yanming Xu

    Published 2023-09-01
    “…Abstract This study aimed to investigate the relationship between venous blood parameters and respiratory functions in patients with amyotrophic lateral sclerosis (ALS) and develop a model to predict respiratory impairment for individual patients with ALS. …”
    Get full text
    Article
  20. 280

    MicroRNA signatures in genetic frontotemporal dementia and amyotrophic lateral sclerosis by Virgilio Kmetzsch, Morwena Latouche, Dario Saracino, Daisy Rinaldi, Agnès Camuzat, Thomas Gareau, the French Research Network on FTD/ALS, Isabelle Le Ber, Olivier Colliot, Emmanuelle Becker

    Published 2022-11-01
    “…Abstract Objective MicroRNAs are promising biomarkers of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), but discrepant results between studies have so far hampered their use in clinical trials. …”
    Get full text
    Article